Methylprednisolone causes matrix metalloproteinase-dependent emphysema in adult rats.
暂无分享,去创建一个
[1] N. Voelkel,et al. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[2] P. Burri,et al. Influence of postnatally administered glucocorticoids on rat lung growth. , 1995, Biology of the neonate.
[3] H. W. Chalkley,et al. A Method for Estimating Volume-Surface Ratios. , 1949, Science.
[4] B. Starcher,et al. The beige mouse: role of neutrophil elastase in the development of pulmonary emphysema. , 1989, Experimental lung research.
[5] L. Davies,et al. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial , 1999, The Lancet.
[6] G. Verleden,et al. What is the optimal treatment strategy for chronic obstructive pulmonary disease exacerbations? , 2002, European Respiratory Journal.
[7] T. Tetley,et al. Emphysema in the blotchy mouse: A morphometric study , 1988, The Journal of pathology.
[8] R. Nagai,et al. Disruption of the klotho gene causes pulmonary emphysema in mice. Defect in maintenance of pulmonary integrity during postnatal life. , 2000, American journal of respiratory cell and molecular biology.
[9] J. Freischlag,et al. Rat and human aortic smooth muscle cells display differing migration and matrix metalloproteinase activities in response to dexamethasone. , 2002, Journal of vascular surgery.
[10] P. Burri,et al. Postnatal lung development and its impairment by glucocorticoids. , 1997, Pediatric pulmonology. Supplement.
[11] P. Hirth,et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. , 2000, The Journal of clinical investigation.
[12] M. Wilkinson. Emphysema in the blotchy mouse: a morphometric study. , 1989, The Journal of pathology.
[13] S. Shapiro,et al. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.
[14] Hiroshi Tanaka,et al. Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in acute asthma. , 2000, The Journal of allergy and clinical immunology.
[15] W. Thurlbeck. Measurement of pulmonary emphysema. , 1967, The American review of respiratory disease.
[16] M. Gaxiola,et al. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. , 2000, Chest.
[17] A. Halbower,et al. Agarose infiltration improves morphology of cryostat sections of lung. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[18] Phillips Yy,et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.
[19] P. Barnes,et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory cell and molecular biology.
[20] A. Churg,et al. Cigarette smoke causes physiologic and morphologic changes of emphysema in the guinea pig. , 1990, The American review of respiratory disease.
[21] H. Sahebjami,et al. Effects of postnatal dexamethasone treatment on development of alveoli in adult rats. , 1989, Experimental lung research.
[22] J. Freischlag,et al. Dexamethasone inhibits vascular smooth muscle cell migration via modulation of matrix metalloproteinase activity. , 2002, The Journal of surgical research.
[23] Thurlbeck Wm. Measurement of pulmonary emphysema. , 1967 .
[24] M. Hoshino,et al. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. , 1999, The Journal of allergy and clinical immunology.
[25] D. Niewoehner,et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. , 1999, The New England journal of medicine.
[26] J. Ambati,et al. Inhibition of VEGF Expression by VEGF RECEPTOR–1 Intrakine , 2004 .
[27] J. Stoller. Acute Exacerbations of Chronic Obstructive Pulmonary Disease , 2002 .
[28] S. Teramoto,et al. A novel model of senile lung: senescence-accelerated mouse (SAM). , 1994, American journal of respiratory and critical care medicine.
[29] A. Churg,et al. Synthetic serine elastase inhibitor reduces cigarette smoke-induced emphysema in guinea pigs. , 2002, American journal of respiratory and critical care medicine.
[30] P. Sly,et al. Lung morphometry after repetitive antenatal glucocorticoid treatment in preterm sheep. , 2001, American journal of respiratory and critical care medicine.